Zhejiang Dawei Pharmaceutical Co., Ltd. was established in 2004. It is a wholly foreign-owned, high-tech manufacturing enterprise specializing in API and intermediates of APIs. The company has a total investment of 8 million U.S. dollars and covers an area of ​​35,000 square meters. It is located in Huzhou City, Zhejiang Province, at the center of Shanghai, Hangzhou, and Jiangsu. The transportation is very convenient. The company has a strong technical force, with a technical team and a team of senior engineers who have been engaged in the research and production of APIs and intermediates for many years, laying a solid foundation for the company's pioneering technology to promote the rapid development of the enterprise. The company has invested in 30 R&D projects in the past three years, and has authorized 16 domestic and foreign patents, all of which have entered the industrialization stage. For better development, it obtained the pharmaceutical GMP certificate in May 2010. In 2013, it was awarded the title of "High-tech Enterprise". A new organization was established in accordance with GMP regulations, equipped with corresponding management departments and management personnel, and the drug production quality management system was improved, enabling the company to meet the requirements of complete facilities, advanced equipment, well-managed, reasonable technology, and stable quality. The company has a GMP plant that meets FDA and COS standards, and can undertake OEM manufacturing of intermediates at home and abroad. The company's main products include: methotrexate, methotrexate disodium, calcium folinate, calcium levofolinate, levofolinic acid, folic acid, cytarabine and so on. The company adheres to the concept of "customer first, honesty, excellence, and technological innovation", and constantly provides customers with high-tech products. Welcome domestic and foreign merchants to gather in Huzhou to create a better tomorrow.

Registered Capital:  8 million (USD)

Registered Address:  No. 818, Xinzhu Road, Huzhou Development Zone

Company Type:  MPR

Business Scope:  Production and sales of amino acids and organic synthetic fermentation products, raw materials (calcium folinate), and feed additives (the feed additive production license is valid until June 14, 2020).